https://www.selleckchem.com/products/loxo-292.html
A software infrastructure and online user interface were built to make the model available to the scientific community. This DNA methylation-based prediction model can be used in the workup for patients with neuroendocrine tumors of unknown primary. To facilitate validation and clinical implementation, we provide a user-friendly, publicly available web-based version of NEN-ID. This DNA methylation-based prediction model can be used in the workup for patients with neuroendocrine tumors of unknown primary. To facilitate validation and cl
Like
Comment
Share
